Comparative safety of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced anaplastic lymphoma kinase-mutated non-small cell lung cancer: Systematic review and network meta-analysis
Yuyao Luo, Zhe Zhang, Xuanzhu Guo, Xuemei Tang, Sijie Li, Guotao Gong, Shun Gao, Yan Zhang, Sheng Lin
Topics & Concepts
MedicineAnaplastic lymphoma kinaseAlectinibCeritinibInternal medicineNeutropeniaCrizotinibRashGastroenterologyLung cancerOncologyPharmacologyToxicityMalignant pleural effusionLung Cancer Treatments and MutationsLymphoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers